Regulatory
Cori Gray, PharmD, Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM, Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP
Successes and Challenges of the Medicare Part D MTM Program
The Importance and Benefits of Smoking-Cessation Therapy
Is the Federal Drug Utilization Review Requirement Just Red Tape or an Enlightened State of Flexibility?
Health Plan Subsidies, Prescription Drugs, and Cost
Implementing Payment Reform in Oncology: Benefits and Challenges
Alan L. Shields, PhD, Yanni Hao, PhD, Meaghan Krohe, PhD, Andrew Yaworsky, Iyar Mazar, MA, Catherine Foley, MPH, MA, Faisal Mehmed, MD, Denise Globe, PhD
Patient-Reported Outcomes in Oncology: Challenges and Opportunities for All Stakeholders
Junling Wang, PhD, Ya-Chen Tina Shih, PhD, Yolanda Qin, Theo Young, BS, Zachary Thomas, MS, MBA, Christina A. Spivey, PhD, David K. Solomon, BSc, PharmD, Marie Chisholm-Burns, PharmD, MPH, MBA, FCCP, FASHP, J. Warren Salmon, PhD
Is It Time to Revisit Medicare Part D?
Financing Drug Innovation: Cost versus Cure
